Yu-Hsiang Hsu

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 10

Top Topics

Dendritic Cells

Insulin Resistance

Top Venues

Cellular & molecular immunology

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Ling-Yu Huang, Chiao-Juno Chiu, Chung-Hsi Hsing, Yu-Hsiang Hsu
Interferon Family Cytokines in Obesity and Insulin Sensitivity. Cells 11 (24) (2022)
Ling-Yu Huang, Chiao-Juno Chiu, Chung-Hsi Hsing, Yu-Hsiang Hsu
Interferon Family Cytokines in Obesity and Insulin Sensitivity. Cells 11 (24) (2022)
Ling-Yu Huang, Chiao-Juno Chiu, Chung-Hsi Hsing, Yu-Hsiang Hsu
Interferon Family Cytokines in Obesity and Insulin Sensitivity. Cells 11 (24) (2022)
Ling-Yu Huang, Chiao-Juno Chiu, Chung-Hsi Hsing, Yu-Hsiang Hsu
Interferon Family Cytokines in Obesity and Insulin Sensitivity. Cells 11 (24) (2022)
Yi-Rou Wu, Chung-Hsi Hsing, Chiao-Juno Chiu, Hsin-Yi Huang, Yu-Hsiang Hsu
Roles of IL-1 and IL-10 family cytokines in the progression of systemic lupus erythematosus: Friends or foes? IUBMB life (2021)
Yu-Hsiang Hsu, Chih-Hsing Wu, Chiao-Juno Chiu, Wei-Ting Chen, Yi-Chieh Chang, Martin Wabitsch, Ming-Shi Chang
IL-20 is involved in obesity by modulation of adipogenesis and macrophage dysregulation. Immunology 164 (4) (2021)
Shao-Wei Lu, Hong-Chin Pan, Yu-Hsiang Hsu, Kung-Chao Chang, Li-Wha Wu, Wei-Yu Chen, Ming-Shi Chang
IL-20 antagonist suppresses PD-L1 expression and prolongs survival in pancreatic cancer models. Nature communications 11 (1) (2020)
Tian-Yu Lin, Yu-Hsiang Hsu
IL-20 in Acute Kidney Injury: Role in Pathogenesis and Potential as a Therapeutic Target. International journal of molecular sciences 21 (3) (2020)
Yu-Hsiang Hsu, Ruey-Mo Lin, Yi-Shu Chiu, Wen-Lung Liu, Kuo-Yuan Huang
Effects of IL-1β, IL-20, and BMP-2 on Intervertebral Disc Inflammation under Hypoxia. Journal of clinical medicine 9 (1) (2020)
Tian-Yu Lin, Chiao-Juno Chiu, Chen-Hsiang Kuan, Fang-Hsu Chen, Yin-Chen Shen, Chih-Hsing Wu, Yu-Hsiang Hsu
IL-29 promoted obesity-induced inflammation and insulin resistance. Cellular & molecular immunology 17 (4) (2019)